Baystate Medical Center
Maternal-Fetal Medicine fellowship · Springfield, MA · Baystate Medical Center programs · Program website
Obstetrics and Gynecology residency here
Incomplete roster. Some resident classes are missing, so the marked trainee numbers may be off, and this program isn't compared with others until it's fixed. It's queued for another look.
- 1*
- Fellows
- 0%*
- Have published here
- 0.00*
- Papers per fellow-year
- —*
- Papers led by a fellow
Roster from the program's own pages 1 · 2, collected 2026-11-08: 1 current fellows in 1 class. Something off? Tell us
Papers
By this program's leadership and fellows since 2022, 9 in all. Updated 2026-11-09.
- Massive fetomaternal hemorrhage and successful prevention of maternal RhD alloimmunization: A case reportSajjad Hassan et al. · Transfusion · 2026 · PubMed
- Outcome data for non‐invasive prenatal testing suggestive of an atypical sex chromosome abnormality of fetal/placental originMatthew Rich et al. · Journal of Genetic Counseling · 2025 · PubMed · cited 1
- Concomitant Peripartum Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) Syndrome and Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (PA-aHUS): Solving This Diagnostic Dilemma with a Unique Case and Literature ReviewMelissa Mia Vega et al. · Journal of the American Society of Nephrology · 2025
- Impact of a Lifestyle Intervention Among Latina Women on Infant Birth and Anthropometric Measures: Pooled Analyses of 2 Randomized Controlled TrialsMadhuri Palnati et al. · Journal of Physical Activity and Health · 2025 · PubMed
- Induction of labor versus expectant management in patients with idiopathic polyhydramniosCorina N. Schoen et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2023 · PubMed · cited 3
- Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohortJulja Burchard et al. · Journal of Medical Economics · 2022 · PubMed · cited 5
- Failure to Detect SARS-CoV-2 RNA in the Air During Active Labor in Mothers Who Recently Tested PositiveCorina N. Schoen et al. · Frontiers in Public Health · 2022 · PubMed · cited 3
- Traction vs no traction in Foley catheter use for induction of labor: a systematic review and meta-analysis of randomized trialsCorina N. Schoen et al. · American Journal of Obstetrics & Gynecology MFM · 2022 · PubMed · cited 17
- Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trialRupsa C. Boelig et al. · American Journal of Obstetrics and Gynecology · 2022 · PubMed · cited 17
How fellows publishauthor positions, co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 1 of 1 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Not compared with other programs yet. Some resident classes are missing. It's queued for another look.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Corina N. Schoen, MDPD | Preterm Birth and Chorioamnionitis; Maternal and Perinatal Health Interventions | 17 | 8 | 3 | 0 | 0.82 |
1 trainees are counted above but never listed by name.
Maternal-Fetal Medicine at Baystate Medical Centershared by every program there, not this program's own
Institution-level: all maternal-fetal medicine publications from Baystate Medical Center and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Maternal-Fetal Medicine research topics at Baystate Medical Center
Papers in the window; each links to the list on OpenAlex.
Most cited at Baystate Medical Center since 2024
All maternal-fetal medicine papers there on OpenAlex
- SUSTAINED REMISSION AND LONG-TERM SURVIVAL OUTCOMES WITH DOSTARLIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH MISMATCH REPAIR DEFICIENT/MICROSATELLITE INSTABILITY-HIGH PRIMARY ADVANCED/RECURRENT ENDOMETRIAL CANCER IN THE ENGOT-EN6-NSGO/GOG-3031/RUBY TRIALVladyslav S. Sukhin et al. · International Journal of Gynecological Cancer · 2026
- 71RO Sustained remission and long-term survival outcomes with dostarlimab plus chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trialV.S. Sukhin et al. · ESMO Open · 2026
- NRG-GY037: A phase III randomized trial of induction chemotherapy and pembrolizumab followed by chemoradiation and pembrolizumab maintenance versus standard chemoradiation and pembrolizumab maintenance in high-risk locally advanced cervical cancer.Jyoti Mayadev et al. · Journal of Clinical Oncology · 2026 · cited 2
- REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS DIAGNOSED WITH ADVANCED ENDOMETRIAL CANCER TREATED WITH IMMUNO-ONCOLOGY THERAPIES IN THE UNITED STATES: 2019-2024Bradley R. Corr et al. · International Journal of Gynecological Cancer · 2025
- 40 Giant Cystic Adenomatoid Tumor of the Uterus: A Comprehensive Case Study of Uncommon Presentation of 15 cm Tumor with Predominant Cystic Growth PatternFnu Poombal et al. · American Journal of Clinical Pathology · 2025
- A randomized, phase III study of sacituzumab govitecan versus treatment of the physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)Ramez Nassef Eskander et al. · International Journal of Gynecological Cancer · 2025 · PubMed · cited 7
- Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trialMansoor Mirza et al. · Gynecologic Oncology · 2025 · cited 1
- Prevalence of SARS-CoV-2 in newborns born to SARS-CoV-2-positive mothers at 2 weeks of lifeSophie Jan et al. · Frontiers in Pediatrics · 2024 · PubMed · cited 1
- Racial Disparities in Surgical Treatment of Uterine Fibroids During the COVID-19 PandemicRebecca Barbaresso et al. · Journal of Women s Health · 2024 · PubMed · cited 2
- 633 Time to deterioration of patient-reported outcomes in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trialIngrid A Boere et al. · International Journal of Gynecological Cancer · 2024 · cited 1
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/baystate-medical-center-mfm"><img src="https://openprograms.org/programs/baystate-medical-center-mfm/badge.svg" alt="Baystate Medical Center Maternal-Fetal Medicine fellowship on OpenPrograms" height="20"></a><iframe src="https://openprograms.org/embed/baystate-medical-center-mfm" title="Recent papers, Baystate Medical Center Maternal-Fetal Medicine fellowship" width="100%" height="520" style="border:0" loading="lazy"></iframe>Something wrong or missing on this page? Use the correction form below; changes show up in both.